Altogether, this shows that CLL cells can relatively rapidly activate Akt phosphorylation independently of BTK kinase activity, which correlates with the extent of ibrutinib-induced lymphocytosis and supports CLL cell survival. The gene discussed is AKT1; the disease is B-cell chronic lymphocytic leukemia.